stella
beta
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above — Stella
Recruiting
Back to Classical Hodgkin Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
University of Pennsylvania, Philadelphia, Pennsylvania
University of Virginia, Charlottesville, Virginia
View full record on ClinicalTrials.gov